Welcome to SynapCell
SynapCell is a biotechnology company providing the CNS drug manufacturing industry with translational drug discovery solutions to reveal the therapeutic potential of their molecules targeting CNS disorders.
Twelfth Eilat Conference on new antiepileptic drugs
August 31 – September 3, 2014
Relocated in Madrid, Spain, August 31 – September 3 for this forthcoming edition, the twelfth Eilat Conference on new antiepileptic drugs (AEDs) will be introducing debates as a new feature. These debates are added to the previous format of in-depth progress report on new antiepileptic drugs in different stages of development, as well as conferences presenting new findings on second-generation treatments.
SynapCell will be presenting its solutions based on the MTLE mouse model of chronic epilepsy and their particular adequacy for drug development in the field during the poster session.
It would be a pleasure to meet you there!
More informations on eilatxii.com